Application of Terminalia chebula tannin chelates in the preparation of drugs or feed additives for the treatment or prevention of swine viral infections
By preparing a chebulic myrobalan tannin chelate preparation, the antioxidant defense function of pigs is enhanced, which solves the problem that existing vaccines cannot protect infected piglets. This achieves effective prevention and treatment of PEDV, PRRSV and ASFV, and improves the immune function and production performance of pigs.
Patent Information
- Application Number
- CN202411805551.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-12-10
- Publication Date
- 2026-11-10
- Estimated Expiration
- 2044-12-10
AI Technical Summary
Existing vaccines are ineffective in protecting infected piglets, leading to frequent outbreaks of viral diseases such as PEDV, PRRSV, and ASFV. There is a lack of safe and side-effect-free treatments or feed additives.
Terminalia chebula tannin chelate or its combination thereof can be used to enhance the body's antioxidant defense function and improve the natural immune function of pigs, and can be prepared into drugs or feed additives for the prevention and treatment of PEDV, PRRSV and ASFV infections.
It significantly inhibits viral replication, reduces disease incidence and mortality, improves pig survival rate and production performance, and is safe with no toxic side effects.
Smart Images

Figure CN119633019B_ABST
Abstract
Description
Technical Field
[0001] This application relates to the field of swine virus prevention and control technology, specifically to the application of Terminalia chebula tannin chelate in the preparation of drugs or feed additives for the treatment or prevention of swine virus infections. Background Technology
[0002] Porcine epidemic diarrhea virus (PEDV), porcine reproductive and respiratory syndrome virus (PRRSV), and African swine fever virus (ASFV) are three common viruses. PEDV is the main cause of PED; it is a coronavirus that can infect pigs of all ages and breeds, but it has a high mortality rate in piglets, with a mortality rate of up to 100% in piglets under seven days old. PEDV mainly infects and replicates in the villous cells of the small intestine, and clinical symptoms include vomiting, diarrhea, and dehydration. PRRSV infection causes porcine reproductive and respiratory syndrome (PRRS), also known as "blue ear disease," a highly contagious disease in pigs characterized by reproductive disorders in pregnant sows (abortion, stillbirth, mummified fetuses) and respiratory diseases in pigs of all ages, especially piglets. African swine fever (ASF) caused by ASFV infection is an acute, febrile, and highly contagious disease characterized by high fever, widespread bleeding in the skin and internal organs, respiratory distress, neurological symptoms, and high mortality.
[0003] Furthermore, since vaccination only prevents viral diseases from occurring and does not protect piglets that are already infected and showing symptoms, relying solely on vaccines can easily lead to immunization failure, and large-scale outbreaks of PEDV, PRRSV, and ASFV viral infections still frequently occur.
[0004] Given the current state of prevention and control of the above viral diseases, the development of therapeutic drugs and methods against swine viruses such as PEDV, PRRSV, and ASFV has become a market need. Summary of the Invention
[0005] In view of this, the purpose of this application is to provide the use of Terminalia chebula tannin chelate in the preparation of drugs or feed additives for the treatment or prevention of swine viral infections. In this application, Terminalia chebula tannin chelate and compositions including Terminalia chebula tannin chelate have antiviral activity against various swine viruses that cause swine diseases, such as PEDV, PRRSV, and ASFV. These drugs or feed additives can be used to prepare drugs or feed additives for the treatment or prevention of swine viruses, which have good efficacy in preventing and treating diseases caused by PEDV, PRRSV, and ASFV, and are highly safe with no toxic side effects.
[0006] To achieve, or at least partially achieve, the above objectives, this application provides the following technical solution:
[0007] Application of Terminalia chebula tannin chelates in the preparation of drugs or feed additives for the treatment or prevention of swine viral infections.
[0008] The technical solution provided in this application has at least the following advantages compared with the prior art:
[0009] 1. The chebulic tannin chelate or composition including chebulic tannin chelate (hereinafter referred to as "chebulic tannin chelate composition") provided in this application has high safety and can be used as a feed additive for a long time to achieve the purpose of preventing diseases. Long-term use will not lead to the emergence of drug-resistant strains or other toxic side effects, which is an advantage that other antiviral drugs do not have.
[0010] 2. The chebulic tannin chelate or chebulic tannin chelate composition provided in this application can effectively prevent and treat PEDV, PRRSV and AFSV infections by enhancing the body's antioxidant defense function, improving the pig's natural immune function and antiviral activity, thereby reducing the incidence of disease and the mortality rate of sick pigs. The chebulic tannin chelate or chebulic tannin chelate composition has significant efficacy in treating and preventing swine viral diseases.
[0011] 3. The results of in vitro experiments show that the chebulic tannin chelate or the chebulic tannin chelate composition has a significant inhibitory effect on the in vitro proliferation of PEDV, PRRSV and ASFV. When chebulic tannin chelate is added to the cell culture medium at a concentration of 100 μg / mL, the TCID50 of PEDV, PRRSV and ASFV on the corresponding cells can be reduced by about 2 to 3 titers.
[0012] 4. In vitro experimental results of this application show that the Terminalia chebula tannin chelate or the Terminalia chebula tannin chelate composition can enhance natural immune function and antiviral activity, effectively prevent and treat PEDV and PRRSV infection, thereby reducing the mortality rate of sick pigs and effectively improving the survival rate and production performance of pigs. The protection rate against PEDV and PRRSV infection can reach 83.3% when administered orally at 20 mg / kg body weight or added to piglet feed. Attached Figure Description
[0013] Figure 1 The image shows the inhibitory effect of copper chebula tannin on PEDV and PRRSV observed by fluorescence microscopy in an embodiment of this application.
[0014] Figure 2 The image provided in this application illustrates the inhibitory effect of chebulic tannin zinc on PEDV and PRRSV observed using a fluorescence microscope in an embodiment of the application. Detailed Implementation
[0015] To make the objectives, technical solutions, and advantages of this application clearer, the following detailed description is provided in conjunction with the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are merely illustrative and not intended to limit the scope of this application.
[0016] Those skilled in the art will understand that, unless otherwise stated, the terms "the," "the," and "the foregoing" used in this application may also include plural forms. It should be further understood that the word "comprising" as used in the specification of this application means the presence of the stated features, steps, or operations, but does not exclude the presence or addition of one or more other features, integers, or steps.
[0017] Those skilled in the art will understand that, where specific experimental steps or conditions are not specified in the embodiments, they can be performed according to the conventional experimental steps or conditions described in the literature in this field; and where the manufacturers of the raw materials or instruments and equipment used are not specified, they are all conventional products that can be obtained commercially.
[0018] Those skilled in the art will understand that, unless otherwise stated in this application, when numerical ranges are given in the embodiments, both endpoints of each numerical range and any value between the two endpoints may be selected. Unless otherwise defined, all technical and scientific terms used in this application, as well as the prior art known to those skilled in the art and the descriptions in this application, can be implemented using any prior art methods, devices, and materials similar to or equivalent to those described, used, or made by means of methods, devices, and materials in the embodiments of this application.
[0019] The term "Terminalia chebula tannin" refers to the main component of Terminalia chebula, accounting for approximately 23.6% to 37.0% of the fruit's weight. Terminalia chebula tannin belongs to the pyrogallol type (hydrolyzable tannins), and is a compound formed by phenolic acids and their derivatives with glucose or polyols through glycosidic or ester bonds. Various hydrolyzable tannins have been found in Terminalia chebula fruit, including: chebulic acid, chebulic acid, chebulic ternary acid, protochebulic acid, chebulin, resveratrol, punicin, chebulin, corilagin, neochebulic acid, ellagic acid, 1,2,3,4,6-penta-O-galloylglucose, 1,6-digalloylglucose, casuarina tannin, 3,4,6-tri-O-galloylglucose, chebulin tannin, galloylglucose, valerin A, valerin B, valerin C, and valeric acid, etc.
[0020] The term "Terminyl tahini chelate" refers to a chelate formed by the complexation of Terminyl tahini and a metal ion. The term "Terminyl tahini copper" is a chelate formed by the complexation of Terminyl tahini and divalent copper ions. The term "Terminyl tahini zinc" is a chelate formed by the complexation of Terminyl tahini and divalent zinc ions.
[0021] This application's embodiments, through in vivo and in vitro experiments, have shown that Terminalia chebula tannin chelates can inhibit the proliferation of viruses such as PEDV, PRRSV, and ASFV, as well as their infection of cells; that is, Terminalia chebula tannin chelates have anti-PED, PRRS, and ASF virus infection effects. This Terminalia chebula tannin chelate and its composition can be used to prepare antiviral drugs and feed additives for the prevention and treatment of swine diseases such as PED, PRRS, and ASF, possessing the advantages of high safety and no toxic side effects.
[0022] Based on this, embodiments of this application provide the application of Terminalia chebula tannin chelate in the preparation of drugs or feed additives for treating or preventing swine viral infections.
[0023] In some embodiments, the swine virus includes at least one of porcine epidemic diarrhea virus, porcine reproductive and respiratory syndrome virus, and African swine fever virus.
[0024] In some embodiments, the drug or feed additive is chebulic tannin chelate, which can be directly used as a drug or feed additive to treat or prevent swine diseases such as PED, PRRS, and ASF.
[0025] In some embodiments, the drug or feed additive is a chebula tannin chelate composition, which includes chebula tannin chelate and excipients, wherein the excipients include at least one selected from anhydrous ethanol, water, Tween-80, lactose, defatted rice bran, corn cob powder, soluble starch, wheat bran, silicon dioxide, montmorillonite, vermiculite, maifanite, and zeolite powder.
[0026] In some embodiments, the chebula tannin chelate composition is a solution of chebula tannin chelate mixed with three solvents: anhydrous ethanol, Tween-80, and water, wherein the concentration of the chebula tannin chelate is 50–100 mg / mL.
[0027] In some embodiments, the chebula tannin chelate composition is a solid mixture of chebula tannin chelate, lactose, and soluble starch, wherein the mass fraction of chebula tannin chelate in the solid mixture is 45% to 55%.
[0028] In some embodiments, the chebula tannin chelate composition is a powdered mixture of chebula tannin chelate and soluble starch or wheat bran, wherein the mass fraction of chebula tannin chelate in the powdered mixture is 45% to 55%.
[0029] In some embodiments, when the drug or feed additive is a chebulic tannin chelate composition, its formulation type includes at least one of oral liquid, granules, tablets, and powders, and the formulation can be prepared using conventional pharmaceutical formulation methods.
[0030] In some preferred embodiments, the chebulic tannin chelate is at least one of chebulic tannin copper and chebulic tannin zinc.
[0031] In some embodiments, the preparation method of the Terminalia chebula tannin chelate is as follows: Terminalia chebula raw material is boiled in water to prepare Terminalia chebula tannin extract, the Terminalia chebula tannin extract is dissolved in hot ethanol at 40-50°C, and the metal salt compound is added at a mass ratio of Terminalia chebula tannin to metal salt compound of 1:1-1.5. The reaction is carried out for 1-3 hours, and the Terminalia chebula tannin chelate is obtained by spray drying.
[0032] In some preferred embodiments, the metal salt compound is at least one of copper chloride and zinc chloride.
[0033] In some embodiments, the method of using the drug or feed additive includes at least one of the following methods:
[0034] (1) Add the chebulic tannin chelate or chebulic tannin chelate combination to the feed at a dosage of 5-20 mg / kg of pig body weight;
[0035] (2) The chebulic tannin chelate or chebulic tannin chelate or chebulic tannin chelate orally was administered at a dose of 5-20 mg / kg of pig body weight.
[0036] (3) Add the chebulic tannin chelate or chebulic tannin chelate combination to the feed at a dosage of 0.05% to 0.5% of the total weight of the pig feed.
[0037] The technical solution of this application and the technical effects achieved will be described in detail below through more specific embodiments.
[0038] Example 1
[0039] This application provides a method for preparing Terminalia chebula tannin copper oral solution, the specific steps of which are as follows:
[0040] (1) Terminalia chebula raw material was boiled in water to prepare Terminalia chebula tannin extract. The Terminalia chebula tannin extract was dissolved in hot ethanol at 45°C. Copper chloride was added at a mass ratio of Terminalia chebula tannin to copper chloride of 1:1.2. The reaction was carried out for 2 hours and then spray-dried to obtain Terminalia chebula tannin copper.
[0041] (2) Weigh out 10g of Terminalia chebula tannin copper, 20mL of anhydrous ethanol and 30mL of Tween-80, and set aside;
[0042] (3) Dissolve copper chebula tannin in anhydrous ethanol, then add Tween-80, and finally add water for injection to make up to 100 mL. Mix well to obtain a copper chebula tannin solution with a concentration of 100 mg / mL, namely the copper chebula tannin oral solution K1.
[0043] Example 2
[0044] This application provides another method for preparing Terminalia chebula tannin copper oral solution, the specific steps of which are as follows:
[0045] (1) Prepare Terminalia chebula tannin copper using the method in step (1) of Example 1;
[0046] (2) Weigh out 5g of Terminalia chebula tannin copper, 20mL of anhydrous ethanol and 30mL of Tween-80, and set aside;
[0047] (3) Dissolve copper chebula tannin in anhydrous ethanol, then add Tween-80, and finally add water for injection to make up to 100 mL. Mix well to obtain a copper chebula tannin solution with a concentration of 50 mg / mL, namely the copper chebula tannin oral solution K2.
[0048] Example 3
[0049] This application provides a method for preparing Terminalia chebula tannin copper granules, the specific steps of which are as follows:
[0050] (1) Prepare Terminalia chebula tannin copper using the method in step (1) of Example 1;
[0051] (2) Weigh out 50g of Terminalia chebula tannin copper, 15g of lactose, and 35g of soluble starch, and set aside;
[0052] (3) Mix chebula tannin copper, lactose and soluble starch, granulate, dry and granulate to obtain granules with a mass fraction of chebula tannin copper of 50%, namely the chebula tannin copper granules K3.
[0053] Example 4
[0054] This application provides a method for preparing Terminalia chebula tannin copper powder, the specific steps of which are as follows:
[0055] (1) Prepare Terminalia chebula tannin copper using the method in step (1) of Example 1;
[0056] (2) Weigh out 50g of Terminalia chebula tannin copper and 50g of soluble starch, and set aside;
[0057] (3) Mix the copper chebula tannin and soluble starch evenly, and pass them through a 60-mesh sieve to obtain a powder with a copper chebula tannin mass fraction of 50%, namely the copper chebula tannin powder K4.
[0058] Example 5
[0059] This application provides a method for preparing Terminalia chebula tannin copper tablets, the specific steps of which are as follows:
[0060] (1) Prepare Terminalia chebula tannin copper using the method in step (1) of Example 1;
[0061] (2) Weigh out 50g of Terminalia chebula tannin copper, 15g of lactose, and 35g of soluble starch, and set aside;
[0062] (3) After mixing the chebula tannin copper, lactose and soluble starch evenly, the mixture is compressed into tablets and dried using a tablet press to obtain tablets with a mass fraction of chebula tannin copper of 50%, namely the chebula tannin tablet K5.
[0063] Example 6
[0064] This application provides a method for preparing Terminalia chebula tannin zinc oral solution, the specific steps of which are as follows:
[0065] (1) Terminalia chebula raw material was prepared by boiling in water to obtain Terminalia chebula tannin extract. The Terminalia chebula tannin extract was dissolved in hot ethanol at 45°C. Zinc chloride was added at a mass ratio of Terminalia chebula tannin to zinc chloride of 1:1.2. The reaction was carried out for 2 hours and then spray-dried to obtain Terminalia chebula tannin zinc.
[0066] (2) Weigh out 10g of Terminalia chebula tannin zinc, 20mL of anhydrous ethanol and 30mL of Tween-80, and set aside;
[0067] (3) Dissolve chebulic tannin zinc in anhydrous ethanol, then add Tween-80, and finally add water for injection to make up to 100 mL. Mix well to obtain a chebulic tannin zinc solution with a concentration of 100 mg / mL, namely the chebulic tannin zinc oral solution K6.
[0068] Example 7
[0069] This application provides a method for preparing Terminalia chebula tannin zinc oral solution, the specific steps of which are as follows:
[0070] (1) Zinc chebula tannin was prepared using the method in step (1) of Example 6;
[0071] (2) Weigh out 5g of Terminalia chebula tannin zinc, 20mL of anhydrous ethanol and 30mL of Tween-80, and set aside;
[0072] (3) Dissolve chebulic tannin zinc in anhydrous ethanol, then add Tween-80, and finally add water for injection to make up to 100 mL. Mix well to obtain a chebulic tannin zinc solution with a concentration of 50 mg / mL, namely the chebulic tannin zinc oral solution K7.
[0073] Example 8
[0074] This application provides a method for preparing Terminalia chebula tannin zinc granules, the specific steps of which are as follows:
[0075] (1) Zinc chebula tannin was prepared using the method in step (1) of Example 6;
[0076] (2) Weigh out 50g of Terminalia chebula tannin zinc, 15g of lactose, and 35g of soluble starch, and set aside.
[0077] (3) Mix chebulic tannin zinc, lactose and soluble starch, granulate, dry and granulate to obtain granules with a mass fraction of chebulic tannin zinc of 50%, namely chebulic tannin zinc granules K8.
[0078] Example 9
[0079] This application provides a method for preparing chebula tannin zinc powder, the specific steps of which are as follows:
[0080] (1) Zinc chebula tannin was prepared using the method in step (1) of Example 6;
[0081] (2) Weigh out 50g of Terminalia chebula tannin zinc and 50g of soluble starch, and set aside;
[0082] (3) Mix the chebulic tannin zinc and soluble starch evenly, and pass them through a 60-mesh sieve to obtain a powder with a mass fraction of 50% chebulic tannin zinc, namely the chebulic tannin zinc powder K9.
[0083] Example 10
[0084] This application provides a method for preparing chebula tannin zinc tablets, the specific steps of which are as follows:
[0085] (1) Zinc chebula tannin was prepared using the method in step (1) of Example 6;
[0086] (2) Weigh out 50g of Terminalia chebula tannin zinc, 15g of lactose, and 35g of soluble starch, and set aside.
[0087] (3) After mixing the chebulic tannin zinc, lactose and soluble starch evenly, the mixture is compressed into tablets and dried using a tablet press to obtain tablets with a chebulic tannin zinc mass fraction of 50%, namely the chebulic tannin zinc tablet K10.
[0088] The formulation and parameters of the Terminalia chebula tannin chelate preparation prepared in the above embodiments are shown in Table 1 below:
[0089] Table 1
[0090] Example number Formulation number Formulation type Components Terminalia chebula tannin chelate concentration Example 1 K1 oral liquid Terminalia chebula tannin copper, anhydrous ethanol, Tween-80 100mg / mL Example 2 K2 oral liquid Terminalia chebula tannin copper, anhydrous ethanol, Tween-80 50mg / mL Example 3 K3 Granules Terminalia chebula, tannins, copper, lactose, soluble starch 50% (mass fraction) Example 4 K4 powder Terminalia chebula tannin copper, soluble starch 50% (mass fraction) Example 5 K5 tablet Terminalia chebula, tannins, copper, lactose, soluble starch 50% (mass fraction) Example 6 K6 oral liquid Terminalia chebula tannin zinc, anhydrous ethanol, Tween-80 100mg / mL Example 7 K7 oral liquid Terminalia chebula tannin zinc, anhydrous ethanol, Tween-80 50mg / mL Example 8 K8 Granules Terminalia chebula, tannins, zinc, lactose, soluble starch 50% (mass fraction) Example 9 K9 powder Terminalia chebula tannin zinc, soluble starch 50% (mass fraction) Example 10 K10 tablet Terminalia chebula, tannins, zinc, lactose, soluble starch 50% (mass fraction)
[0091] Inhibitory effect of Terminalia chebula tannin chelate on porcine virus
[0092] In this application, the inhibitory effects of the prepared chebula tannin copper and chebula tannin zinc on the in vitro proliferation of three porcine viruses, PEDV, PRRSV, and ASFV, were verified using the following methods:
[0093] 1. Materials and Methods:
[0094] 1.1 Virus:
[0095] PEDV YN strain, DR13 strain, PRRSV, and ASFV were isolated and preserved by the State Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University.
[0096] 1.2 Cells:
[0097] African green monkey kidney cells (Vero) were used for the proliferation of PEDV DR13 and YN strains.
[0098] Monkey embryonic kidney epithelial cells (Marc-145) were used for the proliferation of PRRSV;
[0099] Porcine alveolar macrophages (primary cells) were used for the proliferation of ASFV;
[0100] Vero and Marc-145 cells were laboratory-preserved cell lines, and porcine alveolar macrophages were isolated from the lungs of healthy piglets.
[0101] 1.3 Test Drug:
[0102] Terminalia chebula tannin copper and terminalia chebula tannin zinc were prepared according to the aforementioned method;
[0103] 1.4 Reagents: DMEM medium, 1640 medium, trypsin, fetal bovine serum and penicillin-streptomycin were all purchased from GIBCO.
[0104] 1.5 In vitro proliferation inhibition:
[0105] (1) PEDV in vitro proliferation inhibition assay: All in vitro experiments included three experimental groups and one blank group. Different doses of chebulic tannin chelate (chebulic tannin copper or chebulic tannin zinc) were added to the culture medium in the experimental groups: low-dose group (added at 25 μg / mL medium), medium-dose group (added at 50 μg / mL medium), high-dose group (added at 100 μg / mL medium), and blank group (no chebulic tannin copper or chebulic tannin zinc added to the culture medium). Vero cells were infected with the PEDV DR13 strain (MOI = 0.001), with different concentrations of chebulic tannin chelate added simultaneously. 24 h post-infection, the effect of chebulic tannin chelate on the in vitro proliferation of PEDV DR13 strain was investigated using indirect immunofluorescence assay. Simultaneously, PEDV YN strain virus solution was serially diluted 10-fold with DMEM maintenance medium, and 10... -2 10 -3 10 -4 10 -5 10 -6 10 -7 Six dilutions were seeded into 96-well plates containing pre-cultured Vero cell monolayers at 100 μL / well. Each group was supplemented with DMEM maintenance medium containing different concentrations of Terminalia chebula tannin chelate. The plates were incubated at 37°C with 5% CO2 for 48 h, and cytopathic effects were observed. The number of wells with positive cytopathic effects for each dilution was counted, and the TCID for each group was calculated using the Reed-Muench method. 50 Comparing TCIDs of different groups 50 The value was used to determine the inhibitory effect of Terminalia chebula tannin chelate on PEDV proliferation in vitro, and three replicates were performed for each group.
[0106] (2) PRRSV in vitro proliferation inhibition assay: PRRSV was serially diluted 10-fold with DMEM maintenance medium, and 10... -2 10 -3 10 -4 10 -5 10 -6 10 -7 Six dilutions were seeded into 96-well plates containing pre-cultured Marc-145 cell monolayers at 100 μL / well. Each group was supplemented with DMEM maintenance medium containing different concentrations of Terminalia chebula tannin chelate. The plates were incubated at 37°C with 5% CO2 for 72 h, and cytopathic effects were observed. The number of wells with positive cytopathic effects for each dilution was counted, and the TCID for each group was calculated using the Reed-Muench method. 50 Comparing TCIDs of different groups50 The value was used to determine the inhibitory effect of Terminalia chebula tannin chelate on PRRSV proliferation in vitro, and three replicates were performed for each group.
[0107] (3) ASFV in vitro proliferation inhibition assay: ASFV virus solution was serially diluted 10-fold with 1640 maintenance medium, and 10... -2 10 -3 10 -4 10 -5 10 -6 10 -7 Six dilutions were seeded into 96-well plates containing pre-cultured alveolar macrophage monolayers at 100 μL / well. Each group was supplemented with 1640 maintenance medium containing different concentrations of Terminalia chebula tannin chelate. The plates were incubated at 37°C with 5% CO2 for 72 h, and cytopathic effects were observed. The number of positive wells for each dilution was counted, and the TCID of each Poria cocos polysaccharide group was calculated using the Reed-Muench method. 50 Comparing TCIDs of different groups 50 The value was used to determine the inhibitory effect of Terminalia chebula tannin chelate on ASFV proliferation in vitro, and three replicates were performed for each group.
[0108] 1.6 Data Analysis: Experimental data were analyzed using one-way ANOVA and Duncan's method for multiple comparisons in SPSS 13.0 statistical software. P < 0.05 was considered statistically significant, and P < 0.01 was considered highly significant. Results are expressed as mean.
[0109] 2. Experimental Results:
[0110] 2.1 Indirect immunofluorescence assay to evaluate the inhibitory effect of Terminalia chebula tannin chelate on PEDV and PRRSV.
[0111] Figure 1 The image shows the inhibitory effect of copper ternata tannin on PEDV and PRRSV as observed by fluorescence microscopy. Figure 2 The image shows the inhibitory effect of chebulic tannin zinc on PEDV and PRRSV observed under a fluorescence microscope. Figure 1 , 2 As can be seen from the results, the fluorescence signal becomes weaker with the increase of the amount of chebula tannin copper or chebula tannin zinc additive, indicating that the proliferation of PEDV and PRRSV is less. This suggests that chebula tannin copper or chebula tannin zinc has a significant inhibitory effect on the in vitro proliferation of PEDV and PRRSV. Chebula tannin copper or chebula tannin zinc has an effective antiviral effect in vitro, and its antiviral effect shows a significant dose dependence.
[0112] 2.2 Terminalia chebula tannin chelates against different TCID viruses 50 Impact
[0113] Table 2 shows the TCID of different doses of chebulin copper and chebulin zinc against different viruses. 50 The results are affected by the differences, where a, b, c, and d are indicators of significant differences.
[0114] Table 2
[0115]
[0116] Table 2 shows that adding different concentrations of copper chebula tannin or zinc chebula tannin to the cell culture medium significantly affected the TCID of PEDV on Vero cells. 50 The value of PEDV on Vero cells increased with increasing amounts of copper or zinc chebulin tannins. 50 The significant decrease indicates that copper chebula tannin or zinc chebula tannin has a certain inhibitory effect on the proliferation of PRDV in Vero cells cultured in vitro. Adding different concentrations of copper chebula tannin or zinc chebula tannin to the cell culture medium significantly affected the TCID of PRDV in MARC-145 cells. 50 The value of PRRSV on Marc-145 cells was related to the increase in the amount of copper or zinc chebula tannins added. 50 The significant decrease indicates that copper chebula tannin or zinc chebula tannin significantly inhibits the proliferation of PRRSV in Marc-145 cells cultured in vitro. Adding different concentrations of copper chebula tannin or zinc chebula tannin to the cell culture medium significantly affected the TCID of ASFV on alveolar macrophages. 50 The value of ASFV on alveolar macrophages TCID increased with increasing amounts of copper chebulin or zinc chebulin. 50 The significant decrease indicates that chebulic tannin copper or chebulic tannin zinc has a significant inhibitory effect on the in vitro proliferation of ASFV.
[0117] Protective effect of Terminalia chebula tannin chelate composition on PEDV-infected piglets
[0118] This application's embodiments validated the protective effect of Terminalia chebula tannin chelate preparations against PEDV-infected piglets. The validation method is as follows:
[0119] 1. Materials and Methods:
[0120] 1.1 Test virus: PEDV YN strain, donated by the National Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University.
[0121] 1.2 Test drugs: Terminalia chebula tannin copper oral solution K1, Terminalia chebula tannin zinc granules K8.
[0122] 1.3 Experimental Animals: Healthy 3-day-old piglets of the same breed and origin, with similar weight and no maternal antibodies, were selected for the challenge experiment. The piglets were divided into three experimental groups and one control group. Terminalia chebula tannin copper oral solution K1 or terminalia chebula tannin zinc granules K8 were added to the feed of the experimental groups. The low-dose group (added at a dose of 5 mg / kg pig body weight of terminalia tannin copper or terminalia tannin zinc), the medium-dose group (added at a dose of 10 mg / kg pig body weight of terminalia tannin copper or terminalia tannin zinc), the high-dose group (added at a dose of 20 mg / kg pig body weight of terminalia tannin copper or terminalia tannin zinc), and the control group (no terminalia tannin chelate or its preparation was added to the feed) had 12 piglets in each group.
[0123] 1.4 Challenge Test: After feeding for one week, piglets in each group were challenged with 10... 6 TCID 50 Each animal was challenged with PEDV (YN strain) at a concentration of / mL, and each animal was orally orally administered 3.0mL of virus solution. The control group was orally administered the same dose of physiological saline. The animals were then isolated and observed for 7 consecutive days until the end of the experiment.
[0124] 1.5 Observation Indicators: The diarrhea status of experimental piglets was observed daily. At the end of the experimental period, piglets were slaughtered to observe intestinal lesions. The number of dead piglets was also counted, and the diarrhea rate, mortality rate, and protection rate were calculated. The inhibitory effect of Terminalia chebula tannin chelate preparation on PEDV was determined by real-time quantitative PCR detection of the expression level of the PEDV structural gene N in the intestinal mucosa of piglets.
[0125] 1.6 Data Analysis: Experimental data were analyzed using one-way ANOVA and Duncan's method for multiple comparisons in SPSS 13.0 statistical software. P < 0.05 was considered statistically significant, and P < 0.01 was considered highly significant. Results are expressed as mean.
[0126] 2. Experimental Results:
[0127] The morbidity and mortality rates of piglets in each group after adding different doses of Terminalia chebula tannin copper oral solution K1 and Terminalia chebula tannin zinc granules K8 to the feed are shown in Table 3.
[0128] Table 3
[0129]
[0130] Table 3 shows that adding different doses of Terminalia chebula tannin copper oral solution K1 to piglet feed significantly reduced the diarrhea rate and mortality rate of PEDV-infected piglets. Compared with the control group, the diarrhea rate of PEDV-infected piglets decreased to 33.3%–91.7%, while the mortality rate of affected piglets decreased to 16.7%–75%. Adding different doses of Terminalia chebula tannin zinc granules K8 to piglet feed significantly reduced the diarrhea rate and mortality rate of PEDV-infected piglets. Compared with the control group, the diarrhea rate of PEDV-infected piglets decreased to 25%–83.3%, while the mortality rate of affected piglets decreased to 8.3%–66.7%. The experimental results fully demonstrate that the addition of Terminalia chebula tannin copper preparations or Terminalia chebula tannin zinc preparations can significantly improve the protection rate of piglets against PEDV infection.
[0131] The PEDV structural gene N was detected in the intestinal mucosa of the duodenum, jejunum, and ileum of piglets. The results are shown in Table 4 below.
[0132] Table 4
[0133]
[0134] Table 4 shows that adding Terminalia chebula copper oral solution K1 or Terminalia chebula copper granules K8 can significantly reduce the expression level of the N gene of PEDV, which fully demonstrates that adding Terminalia chebula copper oral solution K1 or Terminalia chebula copper granules K8 can significantly reduce the replication of PEDV virus in the small intestine.
[0135] Protective effect of Terminalia chebula tannin chelate composition on PRRSV-infected piglets
[0136] This application's embodiments validated the protective effect of Terminalia chebula tannin chelate preparations against PRRSV-infected piglets. The validation method is as follows:
[0137] 1. Materials and Methods
[0138] 1.1 Test virus: PRRSV, donated by the State Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University.
[0139] 1.2 Test drugs: Terminalia chebula tannin copper tablets K5 and Terminalia chebula tannin zinc powder K9.
[0140] 1.3 Experimental Animals: Healthy 25-day-old piglets of the same breed and origin, with similar weight and no maternal antibodies, were selected for the challenge experiment. The piglets were divided into three experimental groups and one control group. Terminalia chebula tannin copper tablets K5 or terminalia chebula tannin zinc powder K9 were added to the feed of the experimental groups. The low-dose group (added at a dose of 5 mg / kg pig body weight of terminalia tannin copper or terminalia tannin zinc), the medium-dose group (added at a dose of 10 mg / kg pig body weight of terminalia tannin copper or terminalia tannin zinc), the high-dose group (added at a dose of 20 mg / kg pig body weight of terminalia tannin copper or terminalia tannin zinc), and the control group (no terminalia tannin chelate or its preparation was added to the feed) consisted of 12 piglets in each group.
[0141] 1.4 Challenge Test: After feeding for one week, piglets in each group were challenged with 10... 7 TCID 50 Piglets were challenged with PRRSV at a concentration of 5.0 mL / mL, and each piglet was orally administered 5.0 mL of the virus solution. The control group was administered the same amount of physiological saline. The piglets were then isolated and observed for 10–15 days until the end of the experiment.
[0142] 1.5 Observation Indicators: The condition of the experimental piglets was observed daily. At the end of the experimental period, the piglets were slaughtered to observe lung lesions. The number of dead pigs was also recorded, and the morbidity and mortality rates were calculated. The inhibitory effect of the Terminalia chebula tannin chelate preparation on PRRSV was determined by real-time quantitative PCR detection of PRRSV ORF7 gene expression levels in the brain and lungs of piglets.
[0143] 1.6 Data Analysis: Experimental data were analyzed using one-way ANOVA and Duncan's method for multiple comparisons in SPSS 13.0 statistical software. P < 0.05 was considered statistically significant, and P < 0.01 was considered highly significant. Results are expressed as mean.
[0144] 2. Experimental Results:
[0145] Table 5 shows the morbidity and mortality rates of piglets in each group after adding different doses of chebula tannin copper tablets K5 or chebula tannin zinc powder K9 to the feed.
[0146] Table 5
[0147]
[0148] Table 5 shows that oral administration of different doses of chebula tannin copper tablets K5 significantly reduced the morbidity and mortality of PRRSV-infected piglets. Compared with the control group, with increasing dose, the morbidity of PRRSV-infected piglets decreased to 25%–75%, while the mortality rate of infected piglets decreased to 16.7%–50%. Oral administration of different doses of chebula tannin zinc powder K9 significantly reduced the morbidity and mortality of PRRSV-infected piglets. Compared with the control group, with increasing dose, the morbidity of PRRSV-infected piglets decreased to 33.3%–83.3%, while the mortality rate of infected piglets decreased to 16.7%–33.3%. The experimental results fully demonstrate that the addition of chebula tannin copper preparations or chebula tannin zinc preparations can significantly improve the protection rate of piglets against PRRSV infection.
[0149] The expression levels of the PRRSV ORF7 gene in the brain and lungs of piglets were detected, and the results are shown in Table 6 below.
[0150] Table 6
[0151]
[0152] Table 6 shows that the addition of copper chebula tannin tablets K5 or zinc chebula tannin powder K9 can significantly reduce the expression level of the PRRSV ORF7 gene, which fully demonstrates that the addition of copper chebula tannin tablets K5 or zinc chebula tannin powder K9 can significantly reduce the replication of PRRSV in the brain and lungs.
[0153] In summary, the chebulic tannin chelate and chebulic tannin chelate preparations provided in this application have anti-PEDV, PRRSV and ASFV and other swine viruses, and can be used to prepare drugs and feed additives for the treatment and prevention of swine diseases caused by PEDV, PRRSV and ASFV and other swine viruses. The dosage forms of the drugs and feed additives include oral liquid, granules, powder, tablets and other dosage forms.
[0154] The present application has been described in detail above. Specific examples have been used to illustrate the principles and implementation methods of the present application. The descriptions of the embodiments above are only for the purpose of helping to understand the present application and its core ideas. It should be noted that those skilled in the art can make several improvements and modifications to the present application without departing from the principles of the present application, and these improvements and modifications also fall within the protection scope of the claims of the present application.
Claims
1. The application of Terminalia chebula tannin chelates in the preparation of drugs or feed additives for the treatment or prevention of swine viral infections, wherein, The chebulic tannin chelate is at least one of chebulic tannin copper and chebulic tannin zinc, and the porcine virus is porcine reproductive and respiratory syndrome virus. The preparation method of the Terminalia chebula tannin chelate is as follows: Terminalia chebula raw material was prepared into Terminalia chebula tannin extract by boiling in water. The Terminalia chebula tannin extract was dissolved in hot ethanol at 40-50 °C. The metal salt compound was added at a mass ratio of Terminalia chebula tannin to metal salt compound of 1:1-1.
5. The reaction was carried out for 1-3 hours. Terminalia chebula tannin chelate was obtained by spray drying.
2. The application according to claim 1, characterized in that, The drug or feed additive is chebulic tannin chelate.
3. The application according to claim 1, characterized in that, The drug or feed additive is a chebula tannin chelate composition, which includes chebula tannin chelate and excipients. The excipients include at least one of anhydrous ethanol, water, Tween-80, lactose, defatted rice bran, corn cob powder, soluble starch, wheat bran, silicon dioxide, montmorillonite, vermiculite, maifanite, and zeolite powder.
4. The application according to claim 3, characterized in that, The Terminalia chebula tannin chelate composition is at least one of the following (1) to (3): (1) A solution of chebulic tannin chelate mixed with anhydrous ethanol, Tween-80 and water, wherein the concentration of chebulic tannin chelate is 50~100 mg / mL; (2) A solid mixture of Terminalia chebula tannin chelate, lactose, and soluble starch, wherein the mass fraction of Terminalia chebula tannin chelate in the solid mixture is 45% to 55%; (3) A powdered mixture of Terminalia chebula tannin chelate and soluble starch or wheat bran, wherein the mass fraction of Terminalia chebula tannin chelate in the powdered mixture is 45% to 55%.
5. The application according to claim 3, characterized in that, The formulation types of the drug or feed additive include at least one of oral liquid, granules, tablets, and powders, and the formulation can be prepared using conventional pharmaceutical formulation methods.
6. The application according to claim 1, characterized in that, The metal salt compound is at least one of copper chloride and zinc chloride.
